- $4.84bn
- $4.81bn
- $572.39m
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 322 | 375 | 426 | 492 | 572 |
Cost of Revenue | |||||
Gross Profit | 211 | 209 | 264 | 298 | 349 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 290 | 479 | 428 | 500 | 590 |
Operating Profit | 31.9 | -105 | -2.94 | -8.08 | -17.5 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 30.9 | -108 | -3.93 | -10.1 | -21.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 31.1 | -75.1 | -1.48 | -12.3 | -13.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 31.1 | -75.1 | -1.48 | -12.3 | -13.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 31.1 | -75.1 | -1.48 | -12.3 | -13.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.211 | -0.556 | 0.034 | -0.067 | -0.05 |
Dividends per Share |